Skip to main content
OpenTrials

Clinical trial condition

HER2-negative Breast Cancer

Explore clinical trials studying HER2-negative Breast Cancer. Study availability and eligibility vary by location and protocol.

108 public trials 54 recruiting studies
Refine in advanced search Browse all conditions

HER2-negative Breast Cancer trial results

Completed

BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

NCT06253195

Conditions
Advanced Solid Tumor, Breast Cancer, Breast Diseases, +14 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Sun Yat Sen Memorial Hospital, Sun Yat Sen University (South) Guangzhou, Guangdong, China
  • Guangxi Medical University Cancer Hospital Nanning, Guangxi, China
View Trial Details
Completed

ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer

NCT06570031

Conditions
Breast Diseases, Breast Neoplasms, Disease Attributes, +13 more
Locations
  • Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
  • Nagoya University Hospital Nagoya, Aichi-ken, Japan
  • Chiba Cancer Center Chiba, Japan
  • National Cancer Center Hospital East Kashiwa-shi, Chiba, Japan
View all 13 locations
View Trial Details
Completed

A Dose Escalation/Expansion Study of Oral OP-1250 in Subjects With Advanced and/or Metastatic HR+, HER2- Breast Cancer

NCT04505826

Conditions
HER2-negative Breast Cancer, Hormone Receptor Positive Breast Carcinoma
Locations
  • UCLA Hematology/Oncology Los Angeles, California, United States
  • University of Colorado Aurora, Colorado, United States
  • University of Miami, Sylvester Comprehensive Cancer Center Deerfield Beach, Florida, United States
  • Advent Health Orlando, Florida, United States
View all 19 locations
View Trial Details
Completed

Retrospective Study of 2nd-line Therapies After CDK4/6i + Hormonal Therapy in HR+/HER2- Advanced Breast Cancer

NCT05173103

Conditions
Advanced Breast Cancer, HER2-negative Breast Cancer, Hormone Receptor Positive Breast Carcinoma
Locations
  • Clinica Oncologica Aou Ospedali Riuniti Ancona, Italy
  • Ospedale Cardinal Massaia Asti Asti, Italy
  • Ospedale San Martino Belluno, Italy
  • OSPEDALE Sacro Cuore di Gesù - Fatebenefratelli Benevento, Italy
View all 29 locations
View Trial Details
Completed

To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors

NCT05253053

Conditions
Adenocarcinoma, Advanced Solid Tumor, Biliary Tract Cancer, +56 more
Locations
  • The First Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • Hunan Cancer Hospital Changsha, Hunan, China
  • Nanjing Drum Tower Hospital Nanjing, Jiangsu, China
View Trial Details
Completed

A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer

NCT05054374

Conditions
Breast Cancer, Breast Cancer Stage IV, Breast Diseases, +10 more
Locations
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity) Commack, New York, United States
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities) Harrison, New York, United States
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York, United States
View Trial Details
Completed

First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors

NCT05759949

Conditions
Advanced Breast Cancer, Breast Cancer, Breast Diseases, +11 more
Locations
  • Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States
  • Community Cancer Center North Indianapolis, Indiana, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
View Trial Details

Related conditions